 |
|
Updated treatment strategies for intestinal Behçet’s disease
Yong Eun Park, Jae Hee Cheon
Korean J Intern Med. 2018;33(1):1-19. Published online 2017 Dec 8 DOI: https://doi.org/10.3904/kjim.2017.377
|
|
Citations to this article as recorded by
 Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Journal of Gastroenterology and Hepatology.2024; 39(3): 519. CrossRef From skin sensitizers to wastewater: the unknown photo-deactivation process of low-lying excited states of isothiazolinones. A non-adiabatic dynamics investigation
Bruno Bercini de Araújo, Paulo Fernando Bruno Gonçalves
Physical Chemistry Chemical Physics.2024; 26(16): 12799. CrossRef Behcet disease: an undifferentiating and complex vasculitis
Daniel Pak, Hyon Ju Park
Postgraduate Medicine.2023; 135(sup1): 33. CrossRef Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
Seung Bum Lee, Hee Seung Hong, Chang Kyun Lee, Bo-In Lee, Sol Kim, Seong-Joon Koh, Hosun Yu, Jung-Bin Park, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
The Korean Journal of Internal Medicine.2023; 38(5): 661. CrossRef Diarrhoea: An Inflammatory Disorder Mimicking an Infection
Usman Khan, Amr Elseby, Hassan Qureshi
Cureus.2023;[Epub] CrossRef Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)
Jae Hee Cheon, Hyun-Soo Kim, Dong Soo Han, Sung Kook Kim, Sung Jae Shin, Joo Sung Kim, Byong Duk Ye, Geun Am Song, YoungJa Lee, Youngdoe Kim, Yoosun Lee, Won Ho Kim
Gut and Liver.2023; 17(5): 777. CrossRef Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea
Jongwook Yu, Sung Jae Shin, Yune-Jung Park, Hyung Wook Kim, Bo-In Lee, Byong Duk Ye, Geun-Tae Kim, Sung Kook Kim, Joo Sung Kim, Young-Ho Kim, Seonjeong Jeong, Jae Hee Cheon
BMC Gastroenterology.2023;[Epub] CrossRef Efficacy and Safety of Anti-Tumor Necrosis Factor-Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-Analysis
Qingfeng Zhang, Chunyan Ma, Rongrong Dong, Weizhen Xiang, Meiqi Li, Zhenzhen Ma, Qingrui Yang
Yonsei Medical Journal.2022; 63(2): 148. CrossRef Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease
Haruka Miyazaki, Daisuke Watanabe, Norihiro Okamoto, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Namiko Hoshi, Makoto Ooi, Yuzo Kodama
BMC Gastroenterology.2022;[Epub] CrossRef Neuroimaging in 205 consecutive Children Diagnosed with Central Precocious Puberty in Denmark
Anna B. Hansen, Christoffer H. Renault, Ditte Wøjdemann, Peter Gideon, Anders Juul, Rikke Beck Jensen
Pediatric Research.2022;[Epub] CrossRef Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet’s Disease
Takaaki Kawaguchi, Masayuki Fukata, Teppei Omori, Hiroki Kiyohara, Shinya Sugimoto, Kosaku Nanki, Tomohisa Sujino, Yohei Mikami, Takanori Kanai
Crohn's & Colitis 360.2022;[Epub] CrossRef Manifestations of the gastrointestinal tract in systemic rheumatic diseases: A narrative review
E. V. Moroz, T. V. Popkova, A. E. Moroz
Rheumatology Science and Practice.2022; 60(6): 578. CrossRef Experimental Therapeutic Solutions for Behcet’s Disease
Burçin Cansu Bozca, Erkan Alpsoy
Journal of Experimental Pharmacology.2021; Volume 13: 127. CrossRef Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach
Erkan Alpsoy, Pietro Leccese, Giacomo Emmi, Shigeaki Ohno
Frontiers in Medicine.2021;[Epub] CrossRef Behçet Disease: An Update for Dermatologists
Erkan Alpsoy, Burcin Cansu Bozca, Asli Bilgic
American Journal of Clinical Dermatology.2021; 22(4): 477. CrossRef C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
Eun Ae Kang, Jung Won Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Min Soo Cho, Jae Hee Cheon
BMC Gastroenterology.2021;[Epub] CrossRef Advancing diagnostic performance and clinical applicability of deep learning-driven generative adversarial networks for Alzheimer's disease
Changxing Qu, Yinxi Zou, Qingyi Dai, Yingqiao Ma, Jinbo He, Qihong Liu, Weihong Kuang, Zhiyun Jia, Taolin Chen, Qiyong Gong
Psychoradiology.2021; 1(4): 225. CrossRef Behcet’s Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management
Anthony Nguyen, Shubhra Upadhyay, Muhammad Ali Javaid, Abdul Moiz Qureshi, Shahan Haseeb, Nismat Javed, Christopher Cormier, Asif Farooq, Abu Baker Sheikh
Inflammatory Intestinal Diseases.2021; 6(4): 175. CrossRef Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
Intestinal Research.2020; 18(1): 85. CrossRef Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet’s disease
H. J. Kim, K.‑t. Kim, S.-G. Lee, Y. Kim
Zeitschrift für Rheumatologie.2020; 79(7): 702. CrossRef Safety of systemic treatments for Behçet’s syndrome
Giuseppe Lopalco, Donato Rigante, Antonio Lopalco, Giacomo Emmi, Vincenzo Venerito, Antonio Vitale, Giovanna Capozio, Nunzio Denora, Luca Cantarini, Florenzo Iannone
Expert Opinion on Drug Safety.2020; 19(10): 1269. CrossRef The Efficacy of Medium- to Long-term Anti-TNF-α Antibody-based Maintenance Therapy in Behçet's Disease Patients with Intestinal Lesions
Harutaka Kambayashi, Teppei Omori, Satomi Saito, Shun Murasugi, Hiroyuki Kashiwagi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige
Internal Medicine.2020; 59(19): 2343. CrossRef Esophageal Involvement of Behcet’s Disease
Jae Yong Park, Sang Tae Choi, Hee Sung Kim
The Korean Journal of Gastroenterology.2020; 76(6): 337. CrossRef Update on the treatment of Behçet’s syndrome
Sinem Nihal Esatoglu, Gulen Hatemi
Internal and Emergency Medicine.2019; 14(5): 661. CrossRef Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab
Zhe Yan, Bei-Bei Cui, Yong-Yang Yu, Geng Yin, Xiao-Min Cen, Qi-Bing Xie
Medicine.2019; 98(9): e14624. CrossRef Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet’s disease
Naomi Sugimura, Tsutomu Mizoshita, Tomoya Sugiyama, Shozo Togawa, Tomokatsu Miyaki, Taketo Suzuki, Satoshi Tanida, Hiromi Kataoka, Makoto Sasaki
Digestive and Liver Disease.2019; 51(7): 967. CrossRef Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease
Ippei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, Shingo Nakayamada, Kazuyoshi Saito, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Akio Kawabe, Yusuke Miyazaki, Yoshiya Tanaka
Arthritis Research & Therapy.2019;[Epub] CrossRef Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet’s disease
Hyun Jung Lee, Jae Hyeon Kim, Sujeong Hong, Inhwa Hwang, Soo Jung Park, Tae Il Kim, Won Ho Kim, Je-Wook Yu, Seung Won Kim, Jae Hee Cheon
Scientific Reports.2019;[Epub] CrossRef A Case of Henoch-Schönlein Purpura with Fulminant Complications and Its Long-term Outcome
Dong Hyun Lee, Eun-So LEE, Jeong Hong, Kwang-Hwa Park, Ki Soo Pai
Childhood Kidney Diseases.2019; 23(2): 128. CrossRef THE USE OF INTRAVENOUS LASER BLOOD IRRADIATION IN THE TREATMENT OF PATIENTS WITH BEHCET’S SYNDROME
D. F Porsokhonova, V. S Novoselov, A. I Yakubovich, M. A Mirsaidova, Yu. N Radzhabova, Ivan S. Maximov
Russian Journal of Skin and Venereal Diseases.2019; 22(3-4): 104. CrossRef Diagnosing Unusual Presentations of Dopa-Responsive Conditions: Thinking on your Feet
Soumya Sharma, Aditya Murgai, Mandar S. Jog
Canadian Journal of Neurological Sciences / Journa.2018; : 1. CrossRef
|